GP2 is a five-year study led by Andrew Singleton, Ph.D., of the National Institutes of Health and an international team of scientists and researchers.
Members of the steering committee include:
ASAP is working with The Michael J. Fox Foundation to implement the GP2 program. In addition, the Foundation’s sponsored studies – including the Parkinson’s Progression Markers Initiative, BioFIND and Fox Insight – are contributing data and samples to GP2.
A repository of information and links related to the work of the International Parkinson’s Disease Genomics Consortium.
PD GENEration: Mapping the Future of Parkinson’s Disease, is a first-of-its-kind national initiative that offers free genetic testing for clinically relevant Parkinson’s-related genes and free genetic counseling to help participants better understand their results.
A multicenter collaboration across Africa in an effort to increase the knowledge about PD and PD genetics in the region.
A multicenter collaboration across Latin America in an effort to increase the knowledge about PD and PD genetics in the region.
A multicenter collaboration across East Asia in an effort to increase the knowledge about PD and PD genetics in the region.
The Genetic Architecture of Parkinson’s disease in the Indian population (GAP-India) is a multicenter collaboration to increase knowledge about PD in India.